Search Results

Study Shows Avenu Medical’s Ellipsys endoAVF System Reduces Time to Dialysis

September 3, 2020—Richmond Vascular Center in North Chesterfield, Virginia, announced the publication of a study demonstrating that the Ellipsys vascular access system (Avenu Medical, Inc.) reduces the time before patients with kidney failure can begin dialysis treatments while requiring fewer secondary procedures.

Medtronic to Acquire Avenu Medical

September 30, 2020—Medtronic announced it plans to acquire Avenu Medical, developer of the Ellipsys vascular access system for the endovascular creation of arteriovenous (AV) fistula for patients with end-stage renal disease (ESRD) undergoing dialysis.

Medtronic Commences IDE Study of In.Pact AV Access DCB in Patients With End-Stage Renal Disease

May 24, 2017—Medtronic announced that the first patient has been enrolled in a study of the company's In.Pact AV Access drug-coated balloon (DCB) under a US Food and Drug Administration (FDA) investigational device exemption (IDE).

Study Compares Avenu Ellipsys Access System and BD WavelinQ for pAVF Creation

September 10, 2020—Avenu Medical announced the publication of a study comparing the company’s Ellipsys vascular access system and the WavelinQ 4-F system (BD Interventional) for percutaneous arteriovenous fistula (pAVF) in patients with end-stage renal disease.

Pivotal Trial Evaluates Avenu's Ellipsys Vascular Access System

January 3, 2018—Findings from the United States pivotal multicenter trial of the Ellipsys vascular access system (Avenu Medical, Inc.) were published by Jeffrey E. Hull, MD, et al online ahead of print in Journal of Vascular and Interventional Radiology (JVIR). The study evaluated the safety and efficacy of arteriovenous fistulas (AVFs) created with Ellipsys, which is a thermal resistance anastomosis device.

Avenu Medical's Ellipsys Vascular Access System Approved in Europe

June 9, 2016—Avenu Medical, Inc. announced last week that it has received European CE Mark approval for the commercial sale of its single-catheter, image-guided Ellipsys vascular access system for hemodialysis.

Percutaneous AV Fistula Creation Systems Gain FDA Marketing Authorization

June 22, 2018—The US Food and Drug Administration has announced the marketing authorization of two systems designed to percutaneously create arteriovenous (AV) fistulas in hemodialysis patients.

PAD Task Force Urges Passage of ARC Act for Amputation Prevention

December 1, 2020—The CardioVascular Coalition (CVC) announced the publication of an opinion editorial in The Hill calling for lawmakers to support peripheral artery disease (PAD) testing and education to prevent amputations.